ADAR1 Capital Management’s iTeos Therapeutics ITOS Stock Holding History

ADAR1 Capital Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-26,937	Closed	-$269K	–	240
2025 Q2	$269K	Sell	26,937 -74,159	-73%	-$597K	0.04%	144
2025 Q1	$604K	Sell	101,096 -30,503	-23%	-$224K	0.11%	94
2024 Q4	$1.01M	Sell	131,599 -245,138	-65%	-$2.11M	0.2%	76
2024 Q3	$3.85M	Buy	376,737 +316,737	+528%	+$4.83M	0.63%	33
2024 Q2	$890K	Buy	+60,000	New	+$860K	0.17%	69

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADAR1 Capital Management's ITOS Position: Q3 2025 in Review

ADAR1 Capital Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 26,937 shares — an estimated $269K sold.

ADAR1 Capital Management first reported a position in ITOS in Q2 2024 and held it in 5 quarters. The position peaked at $3.85M in Q3 2024. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

ADAR1 Capital Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
ADAR1 Capital Management sold 26,937 iTeos Therapeutics shares in Q3 2025, an estimated $269K.
ADAR1 Capital Management first reported a position in iTeos Therapeutics in Q2 2024 and held it in 5 quarters.
ADAR1 Capital Management's iTeos Therapeutics position peaked at $3.85M in Q3 2024.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on ADAR1 Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.